Paper20147573
A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
Fallon P and 1 other. J Psychopharmacol, 2011. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis. Papers, record 20147573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20147573
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Drug Tolerance | Major topic |
| Movement Disorders | Major topic |
| Schizophrenia | Major topic |
| Adult | |
| Age Factors | |
| Cohort Studies | |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| Life Change Events | |
| Male | |
| Middle Aged | |
| Recurrence | |
| Sex Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RDO/33/94 | Department of Health | United Kingdom | PubMed |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42397413 | Dopamine supersensitivity psychosis: a critical evaluation of diagnostic validators. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/42397413 | PubMed |
| 34355232 | Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data. | Schizophr Bull | 2022 | https://conductscience.org/library/papers/34355232 | PubMed |
| 31487433 | Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5-HT2A receptors in rats. | Neuropsychopharmacol Rep | 2019 | https://conductscience.org/library/papers/31487433 | PubMed |
| 28360793 | Withdrawal-Emergent Dyskinesia and Supersensitivity Psychosis Due to Olanzapine Use. | Noro Psikiyatr Ars | 2016 | https://conductscience.org/library/papers/28360793 | PubMed |
| 27371498 | Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms. | J Psychopharmacol | 2016 | https://conductscience.org/library/papers/27371498 | PubMed |
| 27213069 | Late-Onset Mania in a Patient with Movement Disorder and Basal Ganglia Calcifications: A Challenge for Diagnosis and Treatment. | Case Rep Psychiatry | 2016 | https://conductscience.org/library/papers/27213069 | PubMed |
| 26788394 | Severe Relapsing Clozapine-Withdrawal Catatonia. | Case Rep Psychiatry | 2015 | https://conductscience.org/library/papers/26788394 | PubMed |
| 26694375 | Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/26694375 | PubMed |
| 26346901 | Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism. | CNS Drugs | 2015 | https://conductscience.org/library/papers/26346901 | PubMed |
| 26049127 | Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia. | Brain Res | 2015 | https://conductscience.org/library/papers/26049127 | PubMed |
| 25735995 | Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia. | J Psychopharmacol | 2015 | https://conductscience.org/library/papers/25735995 | PubMed |
| 25478273 | Supersensitivity psychosis and its response to asenapine in a patient with delusional disorder. | Case Rep Psychiatry | 2014 | https://conductscience.org/library/papers/25478273 | PubMed |
| 24942467 | Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood. | Prog Neuropsychopharmacol Biol Psychiatry | 2014 | https://conductscience.org/library/papers/24942467 | PubMed |
| 24467943 | Antipsychotic dosing: found in translation. | J Psychiatry Neurosci | 2014 | https://conductscience.org/library/papers/24467943 | PubMed |
| 24103641 | Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism. | Behav Brain Res | 2013 | https://conductscience.org/library/papers/24103641 | PubMed |
| 23983951 | Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients. | Ther Adv Psychopharmacol | 2012 | https://conductscience.org/library/papers/23983951 | PubMed |
| 23821039 | Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. | CNS Drugs | 2013 | https://conductscience.org/library/papers/23821039 | PubMed |
| 23686527 | Case reports of neuroleptic malignant syndrome in context of quetiapine use. | Psychiatr Q | 2013 | https://conductscience.org/library/papers/23686527 | PubMed |
| 22732209 | Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval. | Behav Pharmacol | 2012 | https://conductscience.org/library/papers/22732209 | PubMed |
| 22249643 | Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone. | Eur Child Adolesc Psychiatry | 2012 | https://conductscience.org/library/papers/22249643 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DRD2 | 1813 | PubTator's text mining | https://conductscience.org/library/genes/1813 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20147573
GET https://conductscience.org/api/papers/v1/20147573/authors